Clinical Trial: Phase 1, Single-site, Single-arm, Clinical Imaging, and Blood-based Biomarker Trial Utilizing 18F-FSPG PET to Guide Therapy in Hepatocellular Carcinoma

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07116486) titled 'Phase 1, Single-site, Single-arm, Clinical Imaging, and Blood-based Biomarker Trial Utilizing 18F-FSPG PET to Guide Therapy in Hepatocellular Carcinoma' on Aug. 07.

Brief Summary: To evaluate the relationship between 18F-FSPG uptake in HCC lesions, ctDNA in blood and clinical response to Y90 radioembolization therapy in patients with hepatocellular carcinoma (HCC) by SOC imaging.

Study Start Date: Dec. 31, 2025

Study Type: INTERVENTIONAL

Condition: Hepatocellular Carcinoma

Intervention: DIAGNOSTIC_TEST: Radiopharmaceutical 18F-FSPG

Given by injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson Cancer Cente...